BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
104 hedge funds and large institutions have $742M invested in bluebird bio in 2014 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 34 increasing their positions, 21 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% more funds holding
Funds holding: 83 → 104 (+21)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
104
Holding in Top 10
1
Calls
$6.52M
Puts
$2.68M
Top Buyers
| 1 | +$25.5M | |
| 2 | +$12.2M | |
| 3 | +$10.7M | |
| 4 |
PC
PointState Capital
New York
|
+$10.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.91M |
Top Sellers
| 1 | -$25M | |
| 2 | -$6.62M | |
| 3 | -$6.57M | |
| 4 |
Millennium Management
New York
|
-$5.81M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$4.33M |